Positives:

First patient dosed in Phase II trial for colorectal cancer treatment

Partnership with Syneos Health and engagement of eight clinical sites

Building on previous promising research in CRC and breast cancer

Targeting large market opportunity with 1.9 million new CRC cases annually

https://www.stocktitan.net/news/CYDY/cyto-dyn...cv6mw.html